None listed
Conditions
Interventions
Oral glucose(device)
Oral glucose(continuous glucose monitoring)
Oral glucose (fingertip sampling)
Oral glucose (venous blood collection)
Sponsors
APO PLUS STATION CO., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Males and females aged 20 years or older at the time of informed consent. 2) Subjects who can make self-judgment and voluntarily gave written informed consent. 3) Subjects whose fasted blood glucose levels are 100 mg/dL or more and less than 126 mg/dL at a health checkup within the past year.
Exclusion criteria
Exclusion criteria: 1)Subjects who are on treatment for a serious illness. 2)Subjects who have been diagnosed with diabetes and under treatment or medication. 3)Subjects who are may develop allergies in connection with the oral glucose tolerance test. 4)Subjects who regularly use licensed drugs or quasi-drugs that may affect the study. 5)Subjects who are currently on treatment at a medical institution for a disease that may affect the study. 6)Subjects who are participating in a clinical trial or have participated in another clinical trial within 1 month before the date of consent for this study. 7)Subjects who are pregnant and those who are breastfeeding. 8)Subjects who plan to participate in another clinical trial during the study period. 9)Subjects who have difficulty in wearing the prototype device. 10)Subjects who have difficulty in wearing continuous glucose monitoring. 11)Subjects who have difficulty in blood drawing from their fingertips by themselves. 12)Subjects who judged as unsuitable for this study by the principal investigator for any reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of glucose level for each of the prototype devices and venous blood sampling, fingertip sampling and continuous glucose monitoring. | — |
Countries
Japan
Contacts
Public ContactMasako Mizuuchi
APO PLUS STATION CO., LTD CRO Business division
Outcome results
None listed